Human gamma delta T-cell receptor-positive cell-mediated inhibition of erythropoiesis in vitro in a patient with type I autoimmune polyglandular syndrome and pure red blood cell aplasia.
The gamma delta T-cell receptor-positive (gamma delta TCR+) lymphocytes were markedly expanded up to 68% of peripheral blood lymphocytes in a case with type I autoimmune polyglandular syndrome and pure red blood cell aplasia (PRCA). The gamma delta TCR+ cells showed CD4 negative, 16% dim-CD8 positive and 10% to 46% human leukocyte antigen-D-related (HLA-DR) positive, and exhibited no monoclonality as assessed by the patterns of TCR gene rearrangements. Functional studies revealed that the proliferative responses of the patient's peripheral blood mononuclear cells (PBMC) were severely depressed to candida antigen, alloantigens, and autoantigens (non-T cells). The gamma delta TCR+ cells had no suppressive effect on the proliferative response of the alpha beta TCR+ cells to candida. The patient's PBMC, isolated gamma delta TCR+ cells but not alpha beta TCR+ cells, exhibited non-major histocompatibility complex (MHC)-restricted cytotoxicity. Furthermore, the patient's PBMC and isolated gamma delta TCR+ cells inhibited burst-forming units-erythroid (BFU-E), but not colony-forming units/granulocyte-macrophage (CFU-GM). Supernatants derived from the patient's T cells similarly inhibited BFU-E but not CFU-GM. The clinical course of the patient also showed a close correlation between the decreased number of total lymphocyte counts, especially HLA-DR + gamma delta TCR+ cell counts, and recovery from PRCA. These observations suggest that the gamma delta TCR+ cells might be functional in vivo and involved in the pathogenesis of PRCA in this patient.
Hara
T
T
Department of Pediatrics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Mizuno
Y
Y
Nagata
M
M
Okabe
Y
Y
Taniguchi
S
S
Harada
M
M
Niho
Y
Y
Oshimi
K
K
Ohga
S
S
Yoshikai
Y
Y
D000328:Adult; D000954:Antigens, Surface / Q000032:analysis / Q000276:immunology; D001327:Autoimmune Diseases / Q000097:blood* / Q000276:immunology / Q000503:physiopathology; D003601:Cytotoxicity Tests, Immunologic; D015672:Erythroid Precursor Cells / Q000187:drug effects; D004920:Erythropoiesis / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D015329:Gene Rearrangement, T-Lymphocyte / Q000276:immunology; D006098:Granulocytes / Q000187:drug effects; D006684:HLA-DR Antigens / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D008264:Macrophages / Q000187:drug effects; D008297:Male; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*; D012010:Red-Cell Aplasia, Pure / Q000097:blood* / Q000209:etiology / Q000503:physiopathology; D013577:Syndrome; D013601:T-Lymphocytes / Q000032:analysis / Q000502:physiology / Q000648:ultrastructure; D014158:Transcription, Genetic / Q000276:immunology
D000954:Antigens, Surface; D006684:HLA-DR Antigens; D011948:Receptors, Antigen, T-Cell